Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
Edo Savelkoul(Radboud University Nijmegen), Frank Hoentjen(Radboud University Nijmegen), Pepijn W. A. Thomas(Radboud University Nijmegen), Lauranne Derikx(Radboud University Nijmegen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Nathan den Broeder(Radboud University Nijmegen)
Cited by 47
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252
Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
|Gastroenterology|2020|233
Reduction of Colitis by Prebiotics in HLA-B27 Transgenic Rats Is Associated with Microflora Changes and Immunomodulation
|Inflammatory Bowel Diseases|2005|215